Apellis Pharmaceuticals Inc. (APLS) Gain 4.35% YTD: Chances Are, Buyers Will Win the Tug-of-War
Apellis Pharmaceuticals Inc. (NASDAQ:APLS) Relative Strength Index (RSI) is 59.88, with weekly volatility at 6.21% and ATR at 3.17. The APLS stock’s 52-week price range